Danny.
You can not be serious.This is the best biotech deal completed for the last 10 years .Not only the potential deal is us $335 million (approx$370 million aussie).The royalty stream at 20% is seriously big .Asuming axiron sell product for $500 million per year the royalty stream for acr is 100 million per year not a bad annuity i would have to say.Lets get the poorly informed sellers from bailleaus out the way and off to the races we go.
lilly to acquire global license to axiron, page-25
Add ACR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.7¢ |
Change
-0.002(2.53%) |
Mkt cap ! $22.38M | |||
| Open | High | Low | Value | Volume |
| 7.8¢ | 7.9¢ | 7.7¢ | $12.27K | 156.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 10092 | 7.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.3¢ | 9000 | 1 |
View Market Depth
| Last trade - 15.49pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
7.7¢ |
Change
-0.002 ( 2.53 %) |
||||
| Open | High | Low | Volume | ||
| 7.7¢ | 7.8¢ | 7.7¢ | 37473 | ||
| Last updated 12.58pm 14/06/2024 ? | |||||
| ACR (ASX) Chart |